Furthermore, the combination of SEP and αPD-L1 induced significantly additive increase of CD3+, CD4+ or CD8+ T cells in tumor compared with SEP (each T cell P < 0.05, respectively, n = 6) or αPD-L1 (each T cell P < 0.05, respectively, n = 6). The gene discussed is CD4; the disease is neoplasm.